Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04760288
Status:
WITHDRAWN
Last Update Posted:
2024-01-05
First Post:
2021-02-17
Brief Title:
A Study of Pralsetinib Versus Standard of Care SOC for Treatment of RET-Mutated Medullary Thyroid Cancer MTC
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-10-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-04-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-17
First Submit QC Date:
February 17 2021
Study First Post Date:
2021-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-04
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL